LLYX

Defiance Daily Target 2x Long LLY ETF
LLYX

19.57 USD
+4.34
28.50%
At close Apr 17, 4:00 PM EDT
After hours
19.50
-0.07
0.36%
1 day
28.50%
5 days
32.05%
1 month
-0.91%
3 months
23.78%
6 months
-27.17%
Year to date
6.30%
1 year
-17.43%
5 years
-17.43%
10 years
-17.43%
0
Funds holding %
of 7,407 funds
–
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

587,071% more capital invested

Capital invested by funds: $354 [Q3] → $2.08M (+$2.08M) [Q4]

984% more call options, than puts

Call options by funds: $477K | Put options by funds: $44K

400% more funds holding

Funds holding: 1 [Q3] → 5 (+4) [Q4]

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

5.82% more ownership

Funds ownership: 0.01% [Q3] → 5.83% (+5.82%) [Q4]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for LLYX.

See Analyst Rankings

Financial journalist opinion

Neutral
ETF Trends
4 months ago
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
Defiance ETFs added another single-stock ETF to its lineup, bringing the total number of 2x leveraged single-stock funds in its offering to five.
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
Positive
ETF Trends
8 months ago
Defiance Lists Leveraged Eli Lilly ETF
On Thursday, Defiance ETFs rolled out its next leveraged fund, the Defiance Daily Target 2X Long LLY ETF (LLYX). The actively managed LLYX has a net expense ratio of 1.29%.
Defiance Lists Leveraged Eli Lilly ETF
See News Rankings
Charts implemented using Lightweight Charts™